日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CLARIX FLO Inhibits DRG Adhesion-Induced Neuropathic Pain Through the CD44-TRPV1 Signaling Pathway

CLARIX FLO 通过 CD44-TRPV1 信号通路抑制 DRG 粘连引起的神经性疼痛

Kung, Chia-Chi; Dai, Shih-Ping; Tu, Chao-Chiang; Tsai, Tsung-An; Chen, Po-Heng; Sung, Chao-Hsien; Fu, Chun-Hsien; Liu, Jen-Hao; Chen, Chih-Li

Hierarchical Data Fusion Algorithm for Multiple Wind Speed Sensors in Anemometer Tower

风速塔中多个风速传感器的分层数据融合算法

Duan, Junhong; Zhang, Hailong; Tu, Chao; Song, Jun; Niu, Wei; Zhang, Zhen; Han, Jinze; Huo, Jiuyuan

Factors Shaping Learning Enthusiasm of the Medical Students: A Comparative Study of Eight-Year and Five-Year Programs

影响医学生学习热情因素:八年制和五年制课程的比较研究

Kang, Jin; Duan, Bin; Wang, Zhao; Len, Wenjie; Peng, Lele; Tu, Chao; Hu, Zhaolan

PKMYT1 kinase ameliorates cisplatin sensitivity in osteosarcoma.

PKMYT1激酶可改善骨肉瘤对顺铂的敏感性

Liu Binfeng, Li Wei, Zhang Wenchao, Feng Chengyao, Wan Lu, He Shasha, Xu Ruiling, Fu Zheng, Liu Zhongyue, Xu Haodong, Jin Xin, Tu Chao, Li Zhihong

Necroptosis in cancer: insight from epigenetic, post-transcriptional and post-translational modifications

癌症中的坏死性凋亡:来自表观遗传、转录后和翻译后修饰的启示

Tang, Jinxin; Zhuang, Yan; Zhang, Yibo; Hu, Hongkun; Wang, Hua; Xu, Haodong; Li, Yintao; Tu, Chao

Bavachalcone targets transferrin receptor and sensitizes gemcitabine to affect bladder cancer progression

巴伐查尔酮靶向转铁蛋白受体,增强吉西他滨对膀胱癌进展的敏感性。

Zhang, Zihao; Yuan, Chenyue; Ge, Qintao; Cao, Dalong; Liu, Wangrui; Xu, Meng; Wang, Mengfei; Feng, Tao; Wang, Yue; Zheng, Shengfeng; Wang, Zhongyuan; Zhang, Wei; Tian, Xi; Huang, Wei; Chen, Ziqi; Tu, Chao; Zhang, Hailiang; Shi, Guohai; Meng, Jialin; Shen, Yijun; Wang, Ziliang; Ye, Dingwei

Anterior Gastropexy for Paraesophageal Hernia Repair: A Randomized Clinical Trial

前壁胃固定术治疗食管旁疝:一项随机临床试验

Petro, Clayton C; Ellis, Ryan C; Maskal, Sara M; Zolin, Sam J; Tu, Chao; Costanzo, Adele; Beffa, Lucas R A; Krpata, David M; Alaedeen, Diya; Prabhu, Ajita S; Miller, Benjamin T; Baier, Kevin F; Fathalizadeh, Alisan; Rodriguez, John; Rosen, Michael J

RFWD3 Reprograms Nucleotide Metabolism Through PHGDH to Induce Chemoresistance In Osteosarcoma.

RFWD3 通过 PHGDH 重编程核苷酸代谢,诱导骨肉瘤产生化疗耐药性

Zhang Wenchao, Yin Chi, Qi Lin, Liu Zhongyue, Xu Ruiling, Tu Chao, Li Zhihong

A Dual Approach with Organoid and CRISPR Screening Reveals ERCC6 as a Determinant of Cisplatin Resistance in Osteosarcoma.

采用类器官和 CRISPR 筛选的双重方法揭示 ERCC6 是骨肉瘤顺铂耐药性的决定因素

Xu Ruiling, Zhu Sai, Zhang Wenchao, Xu Haodong, Tu Chao, Wang Honghui, Wang Lu, He Na, Liu Tang, Guo Xiaoning, Ren Xiaolei, Li Zhihong

Dr. Kinase: predicting the drug-resistance hotspots of protein kinases

激酶博士:预测蛋白激酶的耐药热点

Lin, Shaofeng; Tu, Chao; Hu, Ruifeng; Wang, Haiji; Dong, Zongcheng; Luo, Hui; Kuang, Lan; Wang, Tao; Wang, Liming; Zhao, Zhongming; Li, Zhihong; Xu, Haodong